Bristol Myers Squibb and ConcertAI Announce Launch of Digital Clinical Trial Solution


ConcertAI announced the launch of its new Digital Trial Software-as-a-Service solution. Developed in partnership with Bristol Myers Squibb and powered by ConcertAI's real-world data, Digital Trial Solution integrates clinical research and clinical practice to simplify patient identification, consent, IRB approval, and contract negotiations.

Read more about the solution here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.